Dr. Anand Anbarasu

VIT University, India

Email: [email protected]

Qualifications

2007 Ph.D., Bioinformatics, VIT University, India

2003 M.Tech., Bioinformatics, Sathyabama University, Indiai

1998 M.Sc., Medical Microbiology, Christian Medical College & Hospital, India

1995 B.Sc., Microbiology, Madras University, India

Publications (Selected)

1. Biswas, R., Roy, A., Kayal, T., et al. (2026). Waning immunity and the future of booster vaccination strategies in global vaccine programs post COVID-19. Human Vaccines & Immunotherapeutics, 22(1), Article 2626088.
2. Ragunagam, G. S., Anbarasu, A., & Muthukaliannan, G. K. (2026). Is Fusobacterium nucleatum the key mediator between oral infections and systemic diseases? Mechanistic insights and therapeutic implications. Gut Microbes, 18(1), Article 2694819.
3. Kedari, N., Dey, U., Sreenija, D., et al. (2026). AI/ML-enabled multi-omics integration of host genetics, immunity, and the gut microbiome in Crohn's disease: From diagnosis to theranostics. SLAS Technology, 40, Article 100452.
4. Joshi, G., Rani, S., Bharti, D., et al. (2026). The role of the gut microbiome in antibiotic-driven antimicrobial resistance. Frontiers in Microbiology, 17, Article 1856738.
5. Subramani, T., George, E. A., Saju, A. E., et al. (2026). Biofilm-associated antibiotic tolerance in the era of multidrug resistance: quorum-sensing mechanisms and emerging therapeutic strategies. Frontiers in Cellular and Infection Microbiology, 16, Article 1826282.
6. Jalendiran, H., Roy, A., Sathiyanarayanan, S., et al. (2026). Essential oils as nature-engineered antifungals: a comprehensive review of pharmacological mechanisms, drug synergism, and advanced formulation strategies. Frontiers in Pharmacology, 17, Article 1799031.
7. Joshi, T., Mathpal, S., Kumar, H., et al. (2026). Characterization and targeting of deleterious mutations in Carbapenemase-producing Klebsiella pneumoniae: insights from variant calling, Computer-aided drug design, and DFT analysis. Archives of Microbiology, 208(4), Article 193.
8. Kulandaivelu, R. K., Roy, A., Roy, S., et al. (2026). A comprehensive review of resistome profiles in ocular pathogens: Insights into Pseudomonas aeruginosa and emerging resistance trends. Journal of Infection and Public Health, 19(4), Article 103183.
9. Mazumder, I., Rehman, M., Deshmukh, F., et al. (2026). A review on novel strategies to combat multidrug resistance in pathogenic bacteria exploiting synergism between essential oil and antibiotics. World Journal of Microbiology & Biotechnology, 42(1), Article 36.
10. Venkatesan, B. V., Anbarasu, A., & Muniyan, R. (2025). Comparative analysis of quorum sensing mechanisms in Pseudomonas aeruginosa and Klebsiella pneumoniae: implications for antibiotic resistance. Archives of Microbiology, 208(1), Article 76.
11. Mathpal, S., Panickar, A., Joshi, T., et al. (2025). Genomic surveillance of vancomycin-resistant Enterococcus faecium: a study on Resistome, Plasmidome, and mobilome profiling. Current Genetics, 71(1), Article 26.
12. Anbarasu, S., Balaji, S., Ramaiah, S., et al. (2025). Systems biology-driven identification of biomarkers and significant pathways in radiation-induced hormone-sensitive cancers. Discover Oncology, 16(1), Article 2029.
13. Anbarasu, S., & Anbarasu, A. (2026). Data-Driven Discovery of a Key Regulator Cyclin A2 as a Promising Therapeutic Target in Hormone-Sensitive Cancers. Molecular Biotechnology, 68(5), 2422–2445.
14. Preethi, A. R., Natarajan, S., & Anbarasu, A. (2026). Marmin-Derivatives as Promising Inhibitors of Cysteine Synthases from Mycobacterium Tuberculosis: An in silico Approach. Journal of Computational Biophysics and Chemistry, 25(8), 1255–1272.
15. Balaji, S., Anbarasu, S., Ramaiah, S., et al. (2025). Hispidulin: a potential alternative to vorinostat against HDAC1 for acute myeloid leukemia. Discover Oncology, 16(1), Article 1389.
16. Anbarasu, S., & Anbarasu, A. (2026). Machine Learning-Enabled Network Biology Analysis for Biomarker Discovery: Uncovering Molecular Interactions between Endocrine-Disrupting Chemicals and Hormone-Sensitive Cancers. Journal of Computational Biophysics and Chemistry, 25(6), 945–964.
17. George, E. A., Naha, A., Soundharya, H., et al. (2026). Pharmacokinetics Screening, Molecular Docking, and Dynamics Simulations Revealed Novel Antimicrobial Peptide NKLF2 Mutants as Potent Inhibitors of Mycobacterium tuberculosis. Probiotics and Antimicrobial Proteins, 18(1), 1317–1337.
18. Joshi, T., Priyamvada, P., Mathpal, S., et al. (2025). In-silico evaluation of Azadirachta indica-derived Daucosterol against key viral proteins of Ebolavirus using ML and MD simulations approach. Journal of Biological Physics, 51(1), Article 17.
19. Pearl, S., & Anbarasu, A. (2025). Genomic landscape of nosocomial Acinetobacter baumannii: A comprehensive analysis of the resistome, virulome, and mobilome. Scientific Reports, 15(1), Article 18203.
20. Roy, A., & Anbarasu, A. (2025). Unveiling Berberine analogues as potential inhibitors of Escherichia coli FtsZ through machine learning molecular docking and molecular dynamics approach. Scientific Reports, 15(1), Article 14668.
21. Mathpal, S., Joshi, T., Priyamvada, P., et al. (2025). Machine learning and cheminformatics-based Identification of lichen-derived compounds targeting mutant PBP4R200L in Staphylococcus aureus. Molecular Diversity, 29(4), 3345–3370.
22. Parvez, R., Vijayakumar, S., Vins, A., et al. (2025). Understanding the vaginal microbiome among women with different genotypes of human papillomavirus infection in remote Andaman islands. Frontiers in Cellular and Infection Microbiology, 14, Article 1486166.

Profile Details
https://mbclab.vit.ac.in/contact/
https://scholar.google.com/citations?user=HDaQh5cAAAAJ&hl=en
https://www.researchgate.net/profile/Anand-Anbarasu

WOS ResearcherID: U-6323-2019